# Eloralintide phase 1 trial: weight loss at 12 weeks

Source: https://pepvault.app/research/eloralintide-bhattachar-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Eloralintide](https://pepvault.app/research#eloralintide)

Randomized trial · people

# Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Early human data on eloralintide show weight loss within 12 weeks of weekly dosing, with gut side effects less common than appetite loss, headache and fatigue.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 100
- **Published:** 2026
- **Journal:** Diabetes Obes Metab

## What they tested

The team tested whether once-weekly eloralintide shots, an amylin receptor agonist, were safe and well tolerated, how the drug behaved in the body, and what they did to body weight in people with obesity or overweight.

## How the study was done

A randomized, placebo-controlled, phase 1 trial at US centers, in which 100 people with obesity or overweight (average age 44, 29% women, average BMI 32.6 kg/m2) got weekly shots under the skin of eloralintide or placebo (a dummy shot) for 12 weeks. Neither participants nor investigators knew who got which, and people were placed in 5 cohorts at rising doses, each starting on their full dose without stepping up.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 12, people on eloralintide lost an average of 2.6% to 11.3% of body weight depending on dose group, measured as a least squares mean (a model-adjusted average). Appetite loss was the side effect seen most often, in 19% of people on the drug; others included COVID-19 (11%), fatigue (11%) and headache (12%), and most side effects were mild. Gut problems were less frequent, with vomiting in 4%, nausea in 8% and diarrhea in 10%. Nobody died, and the single serious adverse event, in the 6 mg cohort, was judged not caused by the drug.

## What it doesn’t show

This was a small, 12-week early-stage trial built mainly to check safety and drug levels, so it can't show how weight loss holds up over longer use or in a broader group. Most participants were men, and all were treated at US centers.

## The paper

Bhattachar et al. Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept. Diabetes Obes Metab. 2026.

- [PubMed (PMID 41559929)](https://pubmed.ncbi.nlm.nih.gov/41559929/)
- [The paper (DOI 10.1111/dom.70439)](https://doi.org/10.1111/dom.70439)

## The compound

- [Eloralintide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

## With this study

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Eloralintide

- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025) Randomized trial · people · 2025
- [Every study on Eloralintide](https://pepvault.app/research#eloralintide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking eloralintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Eloralintide](https://pepvault.app/research#eloralintide)

## The library

- [Eloralintide](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
